"Nov\u00E9 l\u00E9\u010Dby, zejm\u00E9na kognitivn\u011B behavior\u00E1ln\u00ED terapie a serotonergn\u00ED l\u00E9ky, pom\u00E1haj\u00ED zm\u00EDrnit p\u0159\u00EDznaky OCD. Na l\u00E9\u010Dbu antidepresivy zareaguje p\u0159ibli\u017En\u011B 50 % posti\u017Een\u00FDch. Ov\u0161em v\u00FDznamn\u00FD po\u010Det pacient\u016F reaguje m\u00E1lo nebo z\u016Fst\u00E1v\u00E1 s v\u00E1\u017Enou rezidu\u00E1ln\u00ED symptomatologi\u00ED.N\u011Bkte\u0159\u00ED z t\u011Bchto pacient\u016F mohou m\u00EDt u\u017Eitek z p\u0159id\u00E1n\u00ED mal\u00FDch d\u00E1vek antipsychotik nebo z augmentace lithiem, buspironem. M\u00E1lo zat\u00EDm v\u00EDme o efektivit\u011B rTMS u t\u00E9to diagn\u00F3zy. Chroni\u010Dt\u00ED refraktern\u00ED pacienti mohou b\u00FDt kandid\u00E1ty na neurochirurgick\u00E9 v\u00FDkony, jako je p\u0159edn\u00ED cingulotomie a capsulotomie." . . "P(1M0517)" . "L\u00E9\u010Dba obsedantn\u011B kompulzivn\u00ED poruchy" . "[B133BF7B1DAB]" . "Psychiatrie" . . . . "11120" . . . "CZ - \u010Cesk\u00E1 republika" . . . "Kosov\u00E1, Ji\u0159ina" . "4"^^ . . "L\u00E9\u010Dba obsedantn\u011B kompulzivn\u00ED poruchy" . . . "Treatment of obsessive compulsive disorder"@en . "1211-7579" . . . "L\u00E9\u010Dba obsedantn\u011B kompulzivn\u00ED poruchy"@cs . "Suppl. 3" . "4"^^ . "Treatment of obsessive compulsive disorder"@en . . "9" . "RIV/00216208:11120/05:00009639!RIV06-MSM-11120___" . "5"^^ . "Treatment; obsessive; compulsive; disorder"@en . "RIV/00216208:11120/05:00009639" . . "Z\u00E1lesk\u00FD, Richard" . . "527907" . . . "Nov\u00E9 l\u00E9\u010Dby, zejm\u00E9na kognitivn\u011B behavior\u00E1ln\u00ED terapie a serotonergn\u00ED l\u00E9ky, pom\u00E1haj\u00ED zm\u00EDrnit p\u0159\u00EDznaky OCD. Na l\u00E9\u010Dbu antidepresivy zareaguje p\u0159ibli\u017En\u011B 50 % posti\u017Een\u00FDch. Ov\u0161em v\u00FDznamn\u00FD po\u010Det pacient\u016F reaguje m\u00E1lo nebo z\u016Fst\u00E1v\u00E1 s v\u00E1\u017Enou rezidu\u00E1ln\u00ED symptomatologi\u00ED.N\u011Bkte\u0159\u00ED z t\u011Bchto pacient\u016F mohou m\u00EDt u\u017Eitek z p\u0159id\u00E1n\u00ED mal\u00FDch d\u00E1vek antipsychotik nebo z augmentace lithiem, buspironem. M\u00E1lo zat\u00EDm v\u00EDme o efektivit\u011B rTMS u t\u00E9to diagn\u00F3zy. Chroni\u010Dt\u00ED refraktern\u00ED pacienti mohou b\u00FDt kandid\u00E1ty na neurochirurgick\u00E9 v\u00FDkony, jako je p\u0159edn\u00ED cingulotomie a capsulotomie."@cs . "Pa\u0161kov\u00E1, Beata" . "Pra\u0161ko, J\u00E1n" . "91;94" . "Newer treatments, specifically cognitive behavioral therapy and serotonergic agents, have helped significantly in symptom amelioration.It is estimated that the symptoms of approximately 50% of patients respond partially to a trial with antidepressants. Consequently, a significant number of patients are left with residual symptoms and disability. Some patients who do not respond to an SRI trial may respond upon addition of a low dose of an antipsychotics. Augmentation with other several agents such as lithium, buspirone, pindolol has been tried with variable success in soma patients. A little is known about efficacy of rTMS in this diagnosis. Chronic refractory OCD causing documented persistent, severe disability is sometimes treated palliatively with neurosurgical procedures such as anterior cingulotomy or anterior capsulotomy."@en . . "L\u00E9\u010Dba obsedantn\u011B kompulzivn\u00ED poruchy"@cs .